Skip to main content

Table 4 Logistic regression analysis of predictors associated with favorable clinical outcome in 132 patients with VAP

From: Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study

 

Multivariate analysis

Variables

OR

95% CI

p value

IH plus IV polymyxin B

2.63

1.06–6.66

0.037

SOFA score

0.87

0.79–0.96

0.005

Septic shock

0.40

0.18–0.91

0.028